VistaGen Therapeutics (VTGN) reported Q2 revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. ADYYF
9. WDAY
10. DVLT

Go back to VistaGen Therapeutics (VTGN) reported Q2 revenue
(NASDAQ: VTGN) Delayed: 0.27 --0 (-0%)
Previous Close $0.27    52 Week High $4.60 
Open $0.27    52 Week Low $2.81 
Day High $0.27    P/E N/A 
Day Low $0.26    EPS $0.00 
Volume 722,380